VIDEO: Updates in pulmonary hypertension highlighted at ATS 2022

SAN FRANCISCO — In this video exclusive, Belinda Natalia Rivera-Lebron, MD, MS, highlights recent updates in the treatment of pulmonary hypertension.

At the American Thoracic Society International Conference, Rivera-Lebron provided a “Clinical Year in Review” update on new advancements in the treatment of pulmonary hypertension, including the recent TRITON study, which compared initial triple oral therapy with double therapy; the INCREASE trial, which evaluated inhaled treprostinil in patients with group 3 pulmonary hypertension; and the PULSAR study, which assessed sotatercept in patients with group 1 PAH.

Rivera-Lebron is an associate professor of medicine and director of the Acute and Chronic Thromboemolism Program at the University of Pittsburgh.

Watch the video for more.

Reference:

• Rivera-Lebron BN, et al. Clinical Year in Review 1. Presented at: American Thoracic Society International Conference; May 13-18, 2022; San Francisco (hybrid meeting).